Real-world experience with PSMA-PET in primary staging and biochemical recurrence settings: data from the Michigan Urological Surgery Improvement Collaborative
PSMA-PET has seen widespread adoption; real world performance characteristics show modest divergence from those reported in clinical trials. Further work will more directly assess the impact of this novel imaging modality on patient management.
Authors
- Michael L. Cher (ORCID: https://orcid.org/0000-0001-9376-6897)
- Deepa Raghavan (ORCID: https://orcid.org/0000-0001-8873-812X)
- Patrick Lewicki (ORCID: https://orcid.org/0000-0002-0692-2909)
- for the Michigan Urological Surgery Improvement Collaborative
- Ava Zamani
- Adam J. Gadzinski (ORCID: https://orcid.org/0000-0003-4562-1284)
- Sabir Meah (ORCID: https://orcid.org/0009-0006-4101-3221)
- Corinne Labardee
- Kassim Salami
- Kevin B Ginsburg
- Jay Lonsway
- Anna Johnson
- Ana Moser
- Tudor Borza
Institutions
- Wayne State University (US)
- University of Michigan (US)
- Gastroenterology Associates Of Western Michigan (US)
- Beaumont Hospital, Royal Oak (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1097/upj.0000000000000998
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00